Panagora Asset Management’s Alaunos Therapeutics TCRT Stock Holding History

Panagora Asset Management’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Hold	0	–	–	–	2360
2015 Q3	–	Sell	-247	Closed	-$408K	–	2419
2015 Q2	$445K	Buy	+247	New	+$383K	﹤0.01%	1379
2015 Q1	–	Sell	-115	Closed	-$87K	–	2384
2014 Q4	$87K	Hold	115	–	–	﹤0.01%	1890
2014 Q3	$46K	Sell	115 -9	-7%	-$4.34K	﹤0.01%	2041
2014 Q2	$75K	Sell	124 -19	-13%	-$10.6K	﹤0.01%	1999
2014 Q1	$98K	Buy	+143	New	+$95.8K	﹤0.01%	1943

Other funds holding TCRT

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Panagora Asset Management's TCRT Position: Q4 2015 in Review

Panagora Asset Management held its Alaunos Therapeutics (TCRT) position steady in Q4 2015 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2360.

Panagora Asset Management first reported a position in TCRT in Q1 2014 and has held it in 5 quarters since. The position peaked at $445K in Q2 2015. 156 funds tracked by Wall St. Rank hold TCRT as of Q4 2015.

Panagora Asset Management held 0 shares of Alaunos Therapeutics worth $0 as of Q4 2015.
Panagora Asset Management left its Alaunos Therapeutics share count unchanged in Q4 2015.
Alaunos Therapeutics made up ﹤0.01% of Panagora Asset Management's portfolio in Q4 2015, its #2360 holding.
Panagora Asset Management first reported a position in Alaunos Therapeutics in Q1 2014 and has held it in 5 quarters since.
Panagora Asset Management's Alaunos Therapeutics position peaked at $445K in Q2 2015.
156 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2015.

Based on Panagora Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.